IE
IDIX

Israel Englander’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Israel Englander’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-54,100
Closed -$1.3M – 4325
2014
Q2 		$1.3M Buy
+54,100
New +$564K ﹤0.01% 2034
2014
Q1 		– Sell
-10,500
Closed -$63K – 4252
2013
Q4 		$63K Sell
10,500
-610,543
-98% -$2.82M ﹤0.01% 3373
2013
Q3 		$3.22M Buy
621,043
+109,212
+21% +$479K 0.01% 1387
2013
Q2 		$1.85M Buy
+511,831
New +$2.09M 0.01% 1636

Israel Englander's IDIX Position: Q3 2014 in Review

Israel Englander sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 54,100 shares — an estimated $1.3M sold.

Israel Englander first reported a position in IDIX in Q2 2013 and held it in 4 quarters. The position peaked at $3.22M in Q3 2013. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Israel Englander reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Israel Englander sold 54,100 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $1.3M.
  • Israel Englander first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • Israel Englander's IDENIX PHARMACEUTICALS INC position peaked at $3.22M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.